Systemic inflammatory reaction after pneumococcal vaccine: a case series.

Author: BanksTaylor A, CollinsLimone C, DuranLaurie L, von EltenKelley A

Paper Details 
Original Abstract of the Article :
Fever, leukocytosis, and large local reactions following the pneumococcal polysaccharide vaccine (PS23) have been described only in isolated case reports in the adult literature. Such atypical reactions can pose difficulty to providers when determining management. Patients experiencing this noninfec...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396240/

データ提供:米国国立医学図書館(NLM)

Pneumococcal Vaccine: Recognizing a Robust Inflammatory Response

This research explores the potential for a robust inflammatory response to the pneumococcal polysaccharide vaccine (PS23), a common vaccine used to protect against pneumococcal infections. The authors present a series of cases highlighting the atypical reactions that can occur after vaccination.

A Misunderstood Reaction: Avoiding Unnecessary Treatment

The authors emphasize the importance of recognizing this noninfectious reaction to avoid unnecessary treatment. This finding, like uncovering a hidden oasis in the desert, provides valuable insights into the potential for vaccine-induced inflammation.

A Call for Awareness: Educating Healthcare Providers

The study highlights the need for healthcare providers to be aware of this atypical reaction and its potential for misdiagnosis. This message, like a beacon in the desert, serves as a reminder to stay vigilant and seek appropriate diagnoses for post-vaccination reactions.

Dr.Camel's Conclusion

This research, like a desert guidebook, sheds light on a potentially overlooked aspect of pneumococcal vaccination. The study encourages healthcare providers to consider the possibility of a robust inflammatory response to the PS23 vaccine, promoting accurate diagnosis and appropriate management of this atypical reaction.
Date :
  1. Date Completed 2015-06-02
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24642659

DOI: Digital Object Identifier

PMC5396240

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.